Aurobindo ties up with Biotechnology Industry Research Assistance Council for COVID-19 vaccine

Aurobindo Pharma said it is developing a vaccine for COVID-19 through its wholly-owned US subsidiary, Auro Vaccines. The vaccine candidate is based on a proprietary vaccine delivery platform of the company.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news